PDS Planning’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Sell |
6,177
-80
| -1% | -$3.07K | 0.02% | 430 |
|
|
2025
Q1 | $242K | Buy |
+6,257
| New | +$242K | 0.02% | 379 |
|
|
2024
Q4 | – | Sell |
-6,173
| Closed | -$252K | – | 453 |
|
|
2024
Q3 | $252K | Buy |
6,173
+849
| +16% | +$34.7K | 0.02% | 347 |
|
|
2024
Q2 | $205K | Buy |
5,324
+230
| +5% | +$8.86K | 0.02% | 357 |
|
|
2024
Q1 | $218K | Buy |
+5,094
| New | +$218K | 0.02% | 342 |
|
|
2022
Q3 | – | Sell |
-4,202
| Closed | -$229K | – | 215 |
|
|
2022
Q2 | $229K | Buy |
+4,202
| New | +$229K | 0.04% | 172 |
|